Royalty Pharma PLC (RPRX)
28.11
+0.13
(+0.46%)
USD |
NASDAQ |
Apr 25, 16:00
28.10
-0.01
(-0.04%)
After-Hours: 20:00
Royalty Pharma Shareholders Equity (Quarterly): 6.526B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.526B |
| September 30, 2023 | 6.139B |
| June 30, 2023 | 6.282B |
| March 31, 2023 | 5.954B |
| December 31, 2022 | 5.628B |
| September 30, 2022 | 6.152B |
| June 30, 2022 | 6.027B |
| March 31, 2022 | 5.778B |
| December 31, 2021 | 5.777B |
| Date | Value |
|---|---|
| September 30, 2021 | 5.793B |
| June 30, 2021 | 5.734B |
| March 31, 2021 | 4.882B |
| December 31, 2020 | 4.819B |
| September 30, 2020 | 4.452B |
| June 30, 2020 | 4.157B |
| March 31, 2020 | 5.160B |
| December 31, 2019 | 6.106B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.157B
Minimum
Jun 2020
6.526B
Maximum
Dec 2023
5.610B
Average
5.778B
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Viatris Inc | 20.47B |
| Walgreens Boots Alliance Inc | 13.48B |
| Pacira BioSciences Inc | 870.13M |
| Amphastar Pharmaceuticals Inc | 639.42M |
| Maravai LifeSciences Holdings Inc | 416.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.38B |
| Total Liabilities (Quarterly) | 6.298B |
| Debt to Equity Ratio | 0.9401 |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 1.56% |